Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells
about
sameAs
Molecular mechanisms of diabetic vascular complicationsOrphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells.SPATA12 and its possible role in DNA damage induced by ultraviolet-C.Transcription factor decoy (TFD) in breast cancer research and treatment.Transcription factors in the pathogenesis of diabetic nephropathy.Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription.Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation.Silica Induces Plasminogen Activator Inhibitor-1 Expression through a MAPKs/AP-1-Dependent Mechanism in Human Lung Epithelial Cells.Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells.Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.Toxicological insight from AP-1 silencing study on proliferation, migration, and dedifferentiation of rat vascular smooth muscle cell.RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis.
P2860
Q33558421-0FD11F47-5C7A-48B9-806E-DD1024315B5FQ33612309-79A7F504-BF71-4DF8-8EEA-F308E1ADA9B2Q35036196-353DD9F7-1651-4CC0-909D-101555A16850Q35081110-E4F6942C-1190-4628-B63A-362524F76827Q37461601-70FE3CB2-E848-46BA-B236-AB1D855C7D41Q38342702-55045BE4-0AFB-4CB1-A342-497E92E851A6Q40735093-3333BE77-29B2-44B3-A274-1D99F9D6C7FBQ43215949-E0609649-F9DA-475C-934F-76026BB92CCEQ44011765-6E348FD6-B459-42E6-BB81-73765DFF4612Q44233121-7D0FDE02-26C9-4B9C-9435-29A6DE4CFB9BQ44493499-9B60779F-2D8C-45AD-82C9-C372631173C4Q44762884-381E559B-BDFB-4431-A94C-96BBD260C391Q53227854-E5D3917A-F88D-4DD7-AB73-284FD36FF17FQ54981633-55BDDDDE-42A4-4FBB-895D-8E03D3D41E60
P2860
Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Transcription factor decoy for ...... n vascular smooth muscle cells
@ast
Transcription factor decoy for ...... n vascular smooth muscle cells
@en
Transcription factor decoy for ...... n vascular smooth muscle cells
@nl
type
label
Transcription factor decoy for ...... n vascular smooth muscle cells
@ast
Transcription factor decoy for ...... n vascular smooth muscle cells
@en
Transcription factor decoy for ...... n vascular smooth muscle cells
@nl
prefLabel
Transcription factor decoy for ...... n vascular smooth muscle cells
@ast
Transcription factor decoy for ...... n vascular smooth muscle cells
@en
Transcription factor decoy for ...... n vascular smooth muscle cells
@nl
P2093
P356
P1433
P1476
Transcription factor decoy for ...... n vascular smooth muscle cells
@en
P2093
R Morishita
P2888
P304
P356
10.1007/S001250051680
P407
P577
2001-06-01T00:00:00Z
P5875
P6179
1024312144